Therapeutic potential of D-amino acid oxidase inhibitors for cognitive impairment associated with schizophrenia: learnings from luvadaxistat

RT Terry-Lorenzo, RH Fan, NA Khin… - International Journal of …, 2025 - academic.oup.com
Hypofunction of the N-methyl-D-aspartate receptor (NMDAR) has been proposed to underlie
the pathophysiology of schizophrenia, suggesting that promoting NMDAR activity may …

Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose …

G De Simone, F Iasevoli, A Barone, V Gaudieri… - Schizophrenia, 2024 - nature.com
Abstract Few studies using Positron Emission Tomography with 18F-fluorodeoxyglucose
(18F-FDG-PET) have examined the neurobiological basis of antipsychotic resistance in …

Glutamate levels and symptom burden in high-risk and first-episode schizophrenia: a dual-voxel study of the anterior cingulate cortex

L Fan, Z Zhang, X Ma, L Liang, Y Wang, L Yuan… - Journal of Psychiatry and …, 2024 - jpn.ca
Background Reduced glutamatergic excitability of the anterior cingulate cortex (ACC) has
been long suspected in schizophrenia; recent observations support low glutamatergic tone …

Defining the disturbance in cortical glutamate and GABA function in psychosis and its origins and consequences

B Deakin, E Liddle, M Rathnaiah, C Gregory, M Katshu… - medRxiv, 2024 - medrxiv.org
It is widely thought that the onset of psychotic symptoms in schizophrenia may arise from an
early neurotoxic phase, possibly related to oxidative stress or inflammation, and a late …

A multistage, dual voxel study of glutamate in the anterior cingulate cortex in schizophrenia supports a primary pyramidal dysfunction model of disorganization

L Fan, Z zhang, X Ma, L Liang, Y Wang, liu Yuan… - bioRxiv, 2023 - biorxiv.org
Background: Schizophrenia is an illness where glutamatergic dysfunction in the anterior
cingulate cortex (ACC) has been long suspected; Recent in vivo evidence (Adams et al …